Mechanisms implicated in the contralateral effect in the central nervous system after unilateral injury: focus on the visual systemFernando Lucas-Ruiz, Caridad Galindo-Romero, Virginia Albaladejo-García, Manuel Vidal-Sanz, Marta Agudo-Barriuso2125-2131
Toward three-dimensional in vitro models to study neurovascular unit functions in health and diseaseTara M.Caffrey, Emily B.Button, Jerome Robert2132-2140
Apolipoprotein A1, the neglected relative of Apolipoprotein E and its potential role in Alzheimer's diseaseKristina Endres2141-2148
Oral frailty and neurodegeneration in Alzheimer's diseaseVittorio Dibello, Madia Lozupone, Daniele Manfredini, Antonio Dibello, Roberta Zupo, Rodolfo Sardone, Antonio Daniele, Frank Lobbezoo, Francesco Panza2149-2153
Non-coding RNAs and other determinants of neuroinflammation and endothelial dysfunction: regulation of gene expression in the acute phase of ischemic stroke and possible therapeutic applicationsMario Daidone, Marco Cataldi, Antonio Pinto, Antonino Tuttolomondo2154-2158
Altered microRNA expression in animal models of Huntington's disease and potential therapeutic strategiesBridget Martinez, Philip V.Peplow2159-2169
Mesenchymal stem cell treatment for peripheral nerve injury: a narrative reviewRui-Cheng Zhang, Wen-Qi Du, Jing-Yuan Zhang, Shao-Xia Yu, Fang-Zhi Lu, Hong-Mei Ding, Yan-Bo Cheng, Chao Ren, De-Qin Geng2170-2176
Corneal neuromediator profiles following laser refractive surgeryLily Wei Yun Yang, Jodhbir S.Mehta, Yu-Chi Liu2177-2183
Neuroimmune connections between corticotropin- releasing hormone and mast cells: novel strategies for the treatment of neurodegenerative diseasesPiplu Bhuiyan, Yi-Wei Wang, Huan-Huan Sha, Hong-Quan Dong, Yan-Ning Qian2184-2197
